Literature DB >> 29600388

Alpha-synuclein is present in dental calculus but not altered in Parkinson's disease patients in comparison to controls.

Sabrina Schmid1, Eva Goldberg-Bockhorn2, Silke Schwarz2,3, Nicole Rotter2,4, Jan Kassubek1, Kelly Del Tredici1, Elmar Pinkhardt1, Markus Otto1, Albert C Ludolph5, Patrick Oeckl1.   

Abstract

INTRODUCTION: In autopsy cases staged for sporadic Parkinson's disease (PD), the neuropathology is characterized by a preclinical phase that targets the enteric nervous system of the gastrointestinal tract (GIT). Therefore, the ENS might be a source of potential (presymptomatic) PD biomarkers.
METHODS: In this clinically based study, we examined the alpha-synuclein (αSyn) concentration in an easily accessible protein storage medium of the GIT, dental calculus, in 21/50 patients with PD and 28/50 age- and gender-matched controls using ELISA.
RESULTS: αSyn was detectable in dental calculus and the median concentration in the control patients was 8.6 pg/mg calculus (interquartile range 2.6-13.1 pg/mg). αSyn concentrations were significantly influenced by blood contamination and samples with a hemoglobin concentration of > 4000 ng/mL were excluded. There was no significant difference of αSyn concentrations in the dental calculus of PD patients (5.76 pg/mg, interquartile range 2.91-9.74 pg/mg) compared to those in controls (p = 0.40).
CONCLUSION: The total αSyn concentration in dental calculus is not a suitable biomarker for sporadic PD. Disease-related variants such as oligomeric or phosphorylated αSyn in calculus might prove to be more specific.

Entities:  

Keywords:  Alpha-synuclein; Biomarker; Dental calculus; Parkinson’s disease; Saliva

Mesh:

Substances:

Year:  2018        PMID: 29600388     DOI: 10.1007/s00415-018-8847-2

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  16 in total

Review 1.  Parkinson's disease.

Authors:  Lorraine V Kalia; Anthony E Lang
Journal:  Lancet       Date:  2015-04-19       Impact factor: 79.321

2.  Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein. A possible molecular NK between Parkinson's disease and heavy metal exposure.

Authors:  V N Uversky; J Li; A L Fink
Journal:  J Biol Chem       Date:  2001-09-11       Impact factor: 5.157

3.  Lewy pathology in the submandibular gland of individuals with incidental Lewy body disease and sporadic Parkinson's disease.

Authors:  Kelly Del Tredici; Christopher H Hawkes; Estifanos Ghebremedhin; Heiko Braak
Journal:  Acta Neuropathol       Date:  2010-03-14       Impact factor: 17.088

Review 4.  The interactions between attrition, abrasion and erosion in tooth wear.

Authors:  R Peter Shellis; Martin Addy
Journal:  Monogr Oral Sci       Date:  2014-06-26

Review 5.  Protein biomarkers in Parkinson's disease: Focus on cerebrospinal fluid markers and synaptic proteins.

Authors:  Steffen Halbgebauer; Patrick Öckl; Katharina Wirth; Petra Steinacker; Markus Otto
Journal:  Mov Disord       Date:  2016-05-02       Impact factor: 10.338

6.  Alpha-, Beta-, and Gamma-synuclein Quantification in Cerebrospinal Fluid by Multiple Reaction Monitoring Reveals Increased Concentrations in Alzheimer's and Creutzfeldt-Jakob Disease but No Alteration in Synucleinopathies.

Authors:  Patrick Oeckl; Fabian Metzger; Magdalena Nagl; Christine A F von Arnim; Steffen Halbgebauer; Petra Steinacker; Albert C Ludolph; Markus Otto
Journal:  Mol Cell Proteomics       Date:  2016-08-09       Impact factor: 5.911

Review 7.  Diagnostic utility of cerebrospinal fluid α-synuclein in Parkinson's disease: A systematic review and meta-analysis.

Authors:  Paolo Eusebi; David Giannandrea; Leonardo Biscetti; Iosief Abraha; Davide Chiasserini; Massimiliano Orso; Paolo Calabresi; Lucilla Parnetti
Journal:  Mov Disord       Date:  2017-09-07       Impact factor: 10.338

8.  Red blood cells are the major source of alpha-synuclein in blood.

Authors:  Robin Barbour; Kristin Kling; John P Anderson; Kelly Banducci; Tracy Cole; Linnea Diep; Michael Fox; Jason M Goldstein; Ferdie Soriano; Peter Seubert; Tamie J Chilcote
Journal:  Neurodegener Dis       Date:  2008-01-04       Impact factor: 2.977

9.  Abnormal Salivary Total and Oligomeric Alpha-Synuclein in Parkinson's Disease.

Authors:  Giorgio Vivacqua; Anna Latorre; Antonio Suppa; Michela Nardi; Sara Pietracupa; Romina Mancinelli; Giovanni Fabbrini; Carlo Colosimo; Eugenio Gaudio; Alfredo Berardelli
Journal:  PLoS One       Date:  2016-03-24       Impact factor: 3.240

10.  Salivary total α-synuclein, oligomeric α-synuclein and SNCA variants in Parkinson's disease patients.

Authors:  Wenyan Kang; Wei Chen; Qiong Yang; Lina Zhang; Linyuan Zhang; Xiaoying Wang; Fangyi Dong; Yang Zhao; Shuai Chen; Thomas J Quinn; Jing Zhang; Shengdi Chen; Jun Liu
Journal:  Sci Rep       Date:  2016-06-23       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.